170 related articles for article (PubMed ID: 37671078)
1. Utility of Prophylactic Percutaneous Gastrostomy in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy: A Multicenter Analysis.
Neves MT; Ferreira A; Branco V; Abreu M; Alves FR; Baptista C; Graça J; Ferreira F; Malheiro M; Martins A
Cureus; 2023 Sep; 15(9):e44637. PubMed ID: 37671078
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
[TBL] [Abstract][Full Text] [Related]
3. Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort.
Dechaphunkul T; Soonthornrak P; Geater SL; Dechaphunkul A
Am J Otolaryngol; 2022; 43(4):103512. PubMed ID: 35636089
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
[TBL] [Abstract][Full Text] [Related]
6. Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.
Dechaphunkul T; Ngamphaiboon N; Danchaivijitr P; Jiratrachu R; Geater SL; Pattaranutaporn P; Jiarpinitnun C; Setakornnukul J; Suktitipat B; Dechaphunkul A
Am J Otolaryngol; 2022; 43(2):103356. PubMed ID: 34972008
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).
Ai X; Zhang P; Xie X; Qiu B; Zhu Y; Zhao L; Xi M; Wu Y; Guo S; Guo J; Liu F; Wang D; Chen N; He Q; Hu Y; Liu M; Ding Z; Liu H
Cancer Med; 2023 Jul; 12(14):15000-15010. PubMed ID: 37326436
[TBL] [Abstract][Full Text] [Related]
8. Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma.
Xu Y; Guo Q; Lin J; Chen B; Wen J; Lu T; Xu Y; Zhang M; Pan J; Lin S
Onco Targets Ther; 2016; 9():6835-6841. PubMed ID: 27853378
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Prophylactic Percutaneous Gastrostomy Placement in Patients with Head and Neck Cancer Treated with Chemoradiotherapy.
Moleiro J; Faias S; Fidalgo C; Serrano M; Pereira AD
Dysphagia; 2016 Feb; 31(1):84-9. PubMed ID: 26487063
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.
Kano S; Tsushima N; Suzuki T; Hamada S; Yokokawa T; Idogawa H; Yasuda K; Minatogawa H; Dekura Y; Aoyama H; Homma A
Int J Clin Oncol; 2021 Jul; 26(7):1179-1187. PubMed ID: 34086112
[TBL] [Abstract][Full Text] [Related]
11. Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation: A Regional Cancer Experience in New Zealand.
Fong SC; Pandey R; Rajaretnam M; Delaibatiki M; Peel DNY
J Med Radiat Sci; 2023 Sep; 70(3):292-300. PubMed ID: 37403761
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer: Influence on nutritional status, utilisation rate and complications.
Hausmann J; Kubesch A; Müller von der Grün J; Goettlich CM; Filmann N; Oliver Tal A; Vermehren J; Friedrich-Rust M; Wächtershäuser A; Bojunga J; Blumenstein I
Int J Clin Pract; 2019 Nov; 73(11):e13405. PubMed ID: 31408231
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
Xu Y; Chen M; Guo Q; Peng H; Guo L; Zong J; Huang H; Chen B; Xu H; Pan J; Lin S
Oral Oncol; 2021 Oct; 121():105435. PubMed ID: 34271334
[TBL] [Abstract][Full Text] [Related]
14. Tube feeding in patients with head and neck cancer undergoing chemoradiotherapy: A systematic review.
Bossola M; Antocicco M; Pepe G
JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1258-1269. PubMed ID: 35244947
[TBL] [Abstract][Full Text] [Related]
15. Malnutrition in head and neck cancer patients: Impacts and indications of a prophylactic percutaneous endoscopic gastrostomy.
Yanni A; Dequanter D; Lechien JR; Loeb I; Rodriguez A; Javadian R; Van Gossum M
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S27-S33. PubMed ID: 30846293
[TBL] [Abstract][Full Text] [Related]
16. Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy.
Baschnagel AM; Yadav S; Marina O; Parzuchowski A; Lanni TB; Warner JN; Parzuchowski JS; Ignatius RT; Akervall J; Chen PY; Krauss DJ
Head Neck; 2014 Aug; 36(8):1155-61. PubMed ID: 23852670
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)?
Madhoun MF; Blankenship MM; Blankenship DM; Krempl GA; Tierney WM
World J Gastroenterol; 2011 Feb; 17(8):1004-8. PubMed ID: 21448351
[TBL] [Abstract][Full Text] [Related]
18. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
Nugent B; Lewis S; O'Sullivan JM
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
[TBL] [Abstract][Full Text] [Related]
19. Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy.
van der Linden NC; Kok A; Leermakers-Vermeer MJ; de Roos NM; de Bree R; van Cruijsen H; Terhaard CH
Nutr Clin Pract; 2017 Apr; 32(2):225-232. PubMed ID: 28362572
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of assessing patient health benefits and incurred costs resulting from early dysphagia intervention during and immediately after chemoradiotherapy for head-and-neck cancer.
Martino R; Ringash J; Durkin L; Greco E; Huang SH; Xu W; Longo CJ
Curr Oncol; 2017 Dec; 24(6):e466-e476. PubMed ID: 29270055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
